279 related articles for article (PubMed ID: 29516324)
21. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
Koga Y; Yasunaga M; Takahashi A; Kuroda J; Moriya Y; Akasu T; Fujita S; Yamamoto S; Baba H; Matsumura Y
Cancer Prev Res (Phila); 2010 Nov; 3(11):1435-42. PubMed ID: 20959518
[TBL] [Abstract][Full Text] [Related]
22. Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer.
Ohigashi S; Sudo K; Kobayashi D; Takahashi O; Takahashi T; Asahara T; Nomoto K; Onodera H
Dig Dis Sci; 2013 Jun; 58(6):1717-26. PubMed ID: 23306850
[TBL] [Abstract][Full Text] [Related]
23. Postoperative Outcomes of Screen-Detected vs Non-Screen-Detected Colorectal Cancer in the Netherlands.
de Neree Tot Babberich MPM; Vermeer NCA; Wouters MWJM; van Grevenstein WMU; Peeters KCMJ; Dekker E; Tanis PJ;
JAMA Surg; 2018 Dec; 153(12):e183567. PubMed ID: 30285063
[TBL] [Abstract][Full Text] [Related]
24. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
Di Giovanni N; Meuwis MA; Louis E; Focant JF
Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
[TBL] [Abstract][Full Text] [Related]
25. [Differences between colorectal cancer patients and healthy people in fecal microbiota and metabolites].
Wang X; Wang J; Rao B; Deng L; Huang Y; Zeng G; Chen C
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Nov; 18(11):1106-10. PubMed ID: 26616803
[TBL] [Abstract][Full Text] [Related]
26. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
[TBL] [Abstract][Full Text] [Related]
27. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients.
Cubiella J; Digby J; Rodríguez-Alonso L; Vega P; Salve M; Díaz-Ondina M; Strachan JA; Mowat C; McDonald PJ; Carey FA; Godber IM; Younes HB; Rodriguez-Moranta F; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Garayoa A; Ferrandez Á; Piñol V; Rodríguez-Alcalde D; Guardiola J; Steele RJ; Fraser CG;
Int J Cancer; 2017 May; 140(10):2201-2211. PubMed ID: 28187494
[TBL] [Abstract][Full Text] [Related]
28. Altered plasma levels of decanoic acid in colorectal cancer as a new diagnostic biomarker.
Crotti S; Agnoletto E; Cancemi G; Di Marco V; Traldi P; Pucciarelli S; Nitti D; Agostini M
Anal Bioanal Chem; 2016 Sep; 408(23):6321-8. PubMed ID: 27379390
[TBL] [Abstract][Full Text] [Related]
29. Repeated screening with fecal immunochemical tests reduced the incidence of colorectal cancers in Saga, Japan.
Sakata N; Sakata Y; Shimoda R; Sakata H; Iwakiri R; Fujimoto K; Mizuguchi M; Irie H; Shimoda Y; Noshiro H
Hepatogastroenterology; 2014; 61(133):1224-8. PubMed ID: 25436287
[TBL] [Abstract][Full Text] [Related]
30. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
31. Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations.
Sinha R; Ahn J; Sampson JN; Shi J; Yu G; Xiong X; Hayes RB; Goedert JJ
PLoS One; 2016; 11(3):e0152126. PubMed ID: 27015276
[TBL] [Abstract][Full Text] [Related]
32. Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening.
Kanaoka S; Yoshida K; Miura N; Sugimura H; Kajimura M
Gastroenterology; 2004 Aug; 127(2):422-7. PubMed ID: 15300574
[TBL] [Abstract][Full Text] [Related]
33. Reduction of novel circulating long-chain fatty acids in colorectal cancer patients is independent of tumor burden and correlates with age.
Ritchie SA; Heath D; Yamazaki Y; Grimmalt B; Kavianpour A; Krenitsky K; Elshoni H; Takemasa I; Miyake M; Sekimoto M; Monden M; Tomonaga T; Matsubara H; Sogawa K; Matsushita K; Nomura F; Goodenowe DB
BMC Gastroenterol; 2010 Nov; 10():140. PubMed ID: 21114854
[TBL] [Abstract][Full Text] [Related]
34. Erythrocyte membrane fatty acids profile in colorectal cancer patients: a preliminary study.
Coviello G; Tutino V; Notarnicola M; Caruso MG
Anticancer Res; 2014 Sep; 34(9):4775-9. PubMed ID: 25202057
[TBL] [Abstract][Full Text] [Related]
35. Fecal microRNA profile in patients with colorectal carcinoma before and after curative surgery.
Rotelli MT; Di Lena M; Cavallini A; Lippolis C; Bonfrate L; Chetta N; Portincasa P; Altomare DF
Int J Colorectal Dis; 2015 Jul; 30(7):891-8. PubMed ID: 25989926
[TBL] [Abstract][Full Text] [Related]
36. Fecal immunochemical test accuracy in familial risk colorectal cancer screening.
Castro I; Cubiella J; Rivera C; González-Mao C; Vega P; Soto S; Hernandez V; Iglesias F; Teresa Alves M; Bujanda L; Fernández-Seara J
Int J Cancer; 2014 Jan; 134(2):367-75. PubMed ID: 23818169
[TBL] [Abstract][Full Text] [Related]
37. Ultra‑performance liquid chromatography coupled with quadrupole time‑of‑flight mass spectrometry‑based metabolic profiling of human serum prior to and following radical resection of colorectal carcinoma.
Chen L; Zhang C; Gui Q; Chen Y; Yang Y
Mol Med Rep; 2015 Nov; 12(5):6879-86. PubMed ID: 26352758
[TBL] [Abstract][Full Text] [Related]
38. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922
[TBL] [Abstract][Full Text] [Related]
39. Veterans' Continued Participation in an Annual Fecal Immunochemical Test Mailing Program for Colorectal Cancer Screening.
Schlichting JA; Mengeling MA; Makki NM; Malhotra A; Halfdanarson TR; Klutts JS; Levy BT; Kaboli PJ; Charlton ME
J Am Board Fam Med; 2015; 28(4):494-7. PubMed ID: 26152441
[TBL] [Abstract][Full Text] [Related]
40. Kinetic analysis of bile acids in the feces of colorectal cancer patients by gas chromatography-mass spectrometry (GC-MS).
Tadano T; Kanoh M; Kondoh H; Matsumoto M; Mimura K; Kanoh Y; Sakamoto K; Kamano T
Rinsho Byori; 2007 May; 55(5):417-27. PubMed ID: 17593686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]